Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Zilver® PTX® with Thumbwheel Delivery System Launched in France

Cook Medical
Posted on: 22 Sep 16

Cook Medical launchesZilver® PTX® drug-eluting peripheral stent thumbwheel delivery system in France. The French Health Ministry has now approved reimbursement for the Zilver PTX thumbwheel delivery system.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160922005773/en/

Zilver® PTX® drug-eluting peripheral stent thumbwheel delivery system (Photo: Business Wire)

The rotating thumbwheel system, which is available for purchase in approved markets across Europe, provides deployment for the world’s first drug-eluting stent for the superficial femoral artery (SFA).

The thumbwheel design features include an ergonomic handle that facilitates single-handed deployment and is available with stents up to 120 mm in length.

About Zilver PTX:

  • Zilver PTX received its initial CE Mark in 2009 and FDA approval in 2012.
  • 5-year data proves that Zilver PTX when compared to Zilver bare-metal stents reduces restenosis and reinterventions.1
  • With its proven drug effect, Zilver PTX inhibits neointimal hyperplasia. 1,2
  • Paclitaxel helps maintain patency by working to prevent restenosis. 2

1 Dake MD, Ansel GM, Jaff MR, et al. Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the Zilver PTX randomized trial. Circulation. 2016;133(15):1472-83.

2 Dake MD, Van Alstine WG, Zhou Q, et al. Polymer-free paclitaxel-coated Zilver PTX Stents—evaluation of pharmacokinetics and comparative safety in porcine arteries. J Vasc Interv Radiol. 2011;22(5):603-610.

About Cook Medical

Since 1963 Cook Medical has worked closely with physicians to develop technologies that eliminate the need for open surgery. Today we are combining medical devices, biologic materials, and cellular therapies to help the world’s healthcare systems deliver better outcomes more efficiently. We have always remained family owned so that we have the freedom to focus on what we care about: patients, our employees, and our communities. Find out more at www.cookmedical.eu, and for the latest news, follow us on Twitter and LinkedIn.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160922005773/en/

Business Wire
www.businesswire.com

Last updated on: 22/09/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.